FindMyKOL

Brian Hollenbeck, MD

Basic profile

New England Baptist Hospital

ORCIDOn fileNPIOn fileSign in to see identifiers
RegionBoston, MA · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 2023FindMyKOL typeFindMyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Brian Hollenbeck is an Infectious Disease physician affiliated with New England Baptist Hospital. OpenAlex indexes 57 publications with 1,340 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
57publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

1,340citations

Citations across these publications.

12h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Becton, Dickinson and Company
    Program year20231 payment
    $130
  • Medtronic, Inc.
    Program year20231 payment
    $63
  • Gilead Sciences, Inc.
    Program year20231 payment
    $41

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    43.1%
    Cephalosporin Antibacterial10.3%
    Cefazolin Sodium60%Ceftriaxone40%
    Part D<11 patients
    Tetracycline-class Drug7.9%
    Doxycycline Hyclate100%
    Part D≥16 patients

    + 5 more classes in this area

  • Cardiovascular

    32.6%
    Statin12%
    Atorvastatin Calcium54%Rosuvastatin Calcium46%
    Part D<11 patients
    Thiazide diuretic7.3%
    Hydrochlorothiazide100%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    7%
    SSRI7%
    Trazodone Hcl100%
    Part D<11 patients
Where care is delivered (Part B)33.6% facility · 66.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”